Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by lscfaon Jan 07, 2021 10:27am
189 Views
Post# 32241504

RE:RHT HIRES LYTHAM PARTNERS AS INVESTOR RELATIONS PROG.

RE:RHT HIRES LYTHAM PARTNERS AS INVESTOR RELATIONS PROG.Reaching cash flow positive (whatever that means) is not enough to justify current share price.....

 

Patients

52,000

42,000

35,000

Rev @ $50 / mo

7,800,000

6,300,000

5,250,000

Gross margin

40%

50%

60%

Gross profit

3,120,000

3,150,000

3,150,000

Cash expenses

1,800,000

1,800,000

1,800,000

Operating income

1,320,000

1,350,000

1,350,000

30% tax

396,000

405,000

405,000

Net income

924,000

945,000

945,000

Shs o/s

178,358,475

178,358,475

178,358,475

eps

$0.005

$0.005

$0.005

Annualized eps

$0.021

$0.021

$0.021

Multiple

20

20

20

Sh value

$0.41

$0.42

$0.42

 

<< Previous
Bullboard Posts
Next >>